Order Article Reprints

Ebrahim F, Tabal S, Lamami Y, Alhudiri IM, El Meshri SE, Al Dwigen S, Arfa R, Alboeshi A, Alemam HA, Abuhtna F, et al. Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 or Post-Vaccination in Libyan Population: Comparison of Four Vaccines. Vaccines. 2022; 10(12):2002. https://doi.org/10.3390/vaccines10122002

Ebrahim, Fawzi, Salah Tabal, Yosra Lamami, Inas M. Alhudiri, Salah Edin El Meshri, Samira Al Dwigen, Ramadan Arfa, Asma Alboeshi, Hafsa A. Alemam, Fauzia Abuhtna, and et al. 2022. "Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 or Post-Vaccination in Libyan Population: Comparison of Four Vaccines" Vaccines 10, no. 12: 2002. https://doi.org/10.3390/vaccines10122002

Ebrahim, F., Tabal, S., Lamami, Y., Alhudiri, I. M., El Meshri, S. E., Al Dwigen, S., Arfa, R., Alboeshi, A., Alemam, H. A., Abuhtna, F., Altrhouni, R., Milad, M. B., Elgriw, N. A., Ruaua, M. A., Abusrewil, Z., Harroush, W., Jallul, M., Ali, F. S., Eltaib, F., & Elzagheid, A. (2022). Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 or Post-Vaccination in Libyan Population: Comparison of Four Vaccines. Vaccines, 10(12), 2002. https://doi.org/10.3390/vaccines10122002